The invention provides methods to identify polymorphisms at the human TLR4 locus, as well as methods to identify individuals at risk of indications that increase their morbidity and mortality.

 
Web www.patentalert.com

< Anti-angiogenic polypeptides

> Interferon-alpha polypeptides and conjugates

> Chimeric immunogens

~ 00502